Press release
Peptide Synthesis Market Size Projected To Reach $8.9 Billion By 2034 With A Cagr Of 9.5%
Peptide Synthesis
What Is the Projected Growth of the Peptide Synthesis Market?
In recent times, there has been significant growth in the peptide synthesis market. The market which was valued at $5.69 billion in 2024, is projected to increase to $6.19 billion in 2025, with a compound annual growth rate (CAGR) of 8.8%. The historical growth can be credited to the surge in peptide-derived vaccines, expansion in biotechnology and biopharmaceuticals, escalated demand for high-purity peptides, as well as regulatory sanctions and standardization.
Anticipations suggest that vigorous expansion is on the horizon for the peptide synthesis market in the upcoming years, reaching a size of $8.9 billion by the year 2029 and indicating a compound annual growth rate (CAGR) of 9.5%. Various factors are contributing to this projected growth, such as the quick development in therapeutic peptides, an escalating demand for customized peptides, their increasing involvement in the discovery and development of drugs, and the emphasis on peptide libraries for screenings. Noteworthy trends expected during the forecast period encompass the emergence of peptide mimetics, embracing novel amino acid derivatives, techniques for peptide cyclization, advancements in solid-phase peptide synthesis (SPPs), and the incorporation of click chemistry.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13295
What Are the Different Peptide Synthesis Market Segments?
The peptide synthesis market covered in this report is segmented -
1) By Product And Service: Reagents, Equipment, Services
2) By Technology: Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology
3) By End User: Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes
Subsegments:
1) By Reagents: Amino Acids, Coupling Reagents, Protecting Groups, Cleavage Reagents
2) By Equipment: Peptide Synthesizers, Chromatography Systems, Mass Spectrometers, Other Analytical Instruments
3) By Services: Custom Peptide Synthesis, Peptide Characterization And Analysis, Peptide Modification Services, Consulting And Support Services
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13295&type=smp
What Are the Primary Drivers Shaping the Peptide Synthesis Market?
The escalation of chronic diseases is projected to amplify the growth of the peptide synthesis market. Chronic conditions, or non-communicable diseases (NCDs), are prolonged health issues that endure over a significant period and frequently progress slowly. Since certain peptides have anti-inflammatory and antioxidant capabilities, peptide synthesis has potential uses for chronic illness, contributing to the deterrence of chronic conditions such as cardiovascular diseases. They could potentially tackle the root causes of chronic illness by focusing on specific cellular processes and signaling pathways, thus offering new therapeutic and management alternatives. For example, the Australian Institute of Health and Welfare, a governmental agency in Australia, revealed in June 2024 that the standardised mortality ratio for chronic conditions had increased to 490 per 100,000 population in 2022, up from 459 per 100,000 population in 2021. Therefore, the surge in chronic diseases is fuelling the expansion of the peptide synthesis market. A rise in healthcare expenditure is anticipated to boost the peptide synthesis market's growth in the future. Healthcare expenditure, referring to the financial resources dedicated to healthcare services, medical procedures, public health schemes, and the healthcare system in general, is a comprehensive metric. There is a considerable expenditure on peptide molecules in pharmaceutical and nutritional sectors due to their therapeutic properties, high specificity, and low toxicity. In December 2023, the U.S. Centers for Medicare & Medicaid Services, a government agency, reported a 4.1% increase in U.S. healthcare spending in 2022, reaching $4.5 trillion. This was a more significant increase than the 3.2% rise observed in 2021. Thus, healthcare outlays are driving the peptide synthesis market's growth.
Which Companies Are Leading in the Peptide Synthesis Market?
Major companies operating in the peptide synthesis market report are Thermo Fisher Scientific, Novo Nordisk A/S, Merck KGaA, Lonza Group, Kaneka Corporation, Uno Minda, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, Mesa Labs Inc., CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd., MP Biomedicals, USV Private Limited, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix
What Are the Major Trends Shaping the Peptide Synthesis Market?
To gain a competitive edge in the peptide synthesis market, major companies are now focusing on introducing next-generation peptide synthesizers like the PurePep Sonata+. This advanced peptide synthesizer provides enhanced efficiency, speed, and accuracy compared to traditional peptide synthesizers. For example, Gyros Protein Technologies, a peptide synthesis and bioanalytical technology services company based in the US, launched the PurePep Sonata+ peptide synthesizer in March 2022. The PurePep Sonata+ builds on the capabilities of the Sonata XT through the inclusion of real-time flow technology, which offers continuous monitoring of fluid flow rates within the system. This innovative method ensures precise and accurate fluid transfers across a wide range of viscosities, in a non-invasive manner.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report
What Are the Top Revenue-Generating Geographies in the Peptide Synthesis Market?
North America was the largest region in the peptide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Peptide Synthesis Market?
2. What is the CAGR expected in the Peptide Synthesis Market?
3. What Are the Key Innovations Transforming the Peptide Synthesis Industry?
4. Which Region Is Leading the Peptide Synthesis Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Synthesis Market Size Projected To Reach $8.9 Billion By 2034 With A Cagr Of 9.5% here
News-ID: 4028550 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
